INOCLON, a flagship enterprise of Gooya Biotech Innovation Co., is the Middle East's pioneering industrial-scale producer of cell culture media and sterile pharmaceuticals. Founded in 2007, we supply globally recognized research institutions and pharmaceutical partners under our proprietary INOCLON® brand. Our GMP/ISO-certified manufacturing facilities deliver precision engineered solutions including cell culture media, ophthalmic drops, nasal sprays, nutraceuticals and cosmetics.
Guided by our mission, "Your Health, Our Innovative Approach", we integrate cutting-edge biotechnology with uncompromising quality control to address critical healthcare challenges. Today, INOCLON is expanding its portfolio of pharmaceutical innovations while advancing regional self-sufficiency in drug production. We remain committed to sustainable practices, strategic R&D partnerships, and a vision of making high-impact therapeutics accessible worldwide.
Company Details
- Employees
- 18
- Address
- Critical Healthcare Challenges. Today
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://inoclon.com/
Inoclon Questions
Inoclon's website is https://inoclon.com/
Inoclon's LinkedIn profile is https://www.linkedin.com/company/inoclon-co
Inoclon has
18 employees.
View email and phone details for 18
employees at Inoclon.
Inoclon's industry is
Pharmaceutical Manufacturing
Inoclon's top competitors are
Loghman Pharmaceutical & Hygienic Co.,
Cobel Group®,
Cinnagen,
Tachra Darou,
Vira Pajohan Kavir Gene,
Medvac Biopharma,
Darou Pakhsh (شرکت کارخانجات داروپخش),
Dr.behrouz.pharmacy,
Aryogen Pharmed,
Actoverco.
Inoclon's categories are Pharmaceutical Manufacturing
